Profesor Yu Zaixin adalah pakar senior kardiologi terkenal di Tiongkok. Beliau memiliki pengalaman klinis yang luas dan pencapaian akademis yang mendalam di bidang penyakit kardiovaskular. Pada tahun 2021, beliau dinobatkan sebagai salah satu dari 50 ahli pengobatan kardiovaskular terbaik di Tiongkok. Peneliti pascadoktoral di Universitas Stanford di Amerika Serikat, dari tahun 1996-1997 dan 2000-2001 beliau mempelajari diagnosis intervensi jantung dan teknologi pengobatan di Shiga Adult Disease Center di Jepang. Profesor Yu pandai dalam menangani berbagai penyakit kardiovaskular, termasuk penyakit jantung koroner, hipertensi, aritmia, dll. Beliau mahir dalam perawatan intervensi jantung seperti intervensi koroner (PCI) dan implantasi alat pacu jantung.

Profesor Yu juga telah mencapai prestasi luar biasa dalam penelitian ilmiah medis, Beliau telah berpartisipasi dalam sejumlah proyek penelitian ilmiah nasional dan provinsi dan menerbitkan banyak makalah akademis di jurnal inti baik dalam dan luar negeri. Selain itu, beliau menjabat sebagai reviewer dan anggota dewan editorial untuk beberapa jurnal medis dan telah memberikan kontribusi positif dalam mempromosikan pengembangan teknologi diagnosis dan pengobatan penyakit kardiovaskular.

Profesor Yu memiliki reputasi tinggi di kalangan pasien, dan keterampilan medis serta etika medisnya telah diakui secara luas oleh pasien. Beliau berfokus pada komunikasi dengan pasien dan pandai dalam menjawab pertanyaan mereka, membantu pasien memahami kondisi mereka dan merumuskan rencana perawatan yang tepat. Di bawah kepemimpinannya, pusat ini telah menjadi pusat diagnosis dan pengobatan penyakit kardiovaskular dengan reputasi tinggi.

Bagian Makalah:

1.Yundai,Chen,Lei,Gao,Qin,Qin,Jun,Zhang,Shaobin,Jia,Mingxing,Wu,Yong,He,Guosheng,Fu,Jinghua,Liu,Hui,Chen,Qian,Tong,Zaixin,Yu,Jian,An,Chunguang,Qiu,Biao,Xu,Yu,Cao,Changqian,Wang,Genshan,Ma.Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial.[J].EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,2024,20(13):e806-e817.DOI:10.4244/EIJ-D-24-00295.

2.Xiaofang,Zeng,Jing,Sun,Famei,Li,Liming,Peng,Chenglong,Zhang,Xiaowei,Jiang,Lihuang,Zha,Anandharajan,Rathinasabapathy,Jun,Ren,Zaixin,Yu,Lin,Wang,Xiangwei,Liu.Beclin 1 Haploinsufficiency Ameliorates High-Fat Diet-Induced Myocardial Injury Inhibiting AlternativeMitophagy.[J].Antioxidants & redox signaling,2024,40(16-18):906-925.DOI:10.1089/ars.2023.0399.

3.Yiyang,Tang,Zhenghui,Liu,Qin,Chen,Mukamengjiang,Juaiti,Zaixin,Yu,Benhui,Liang,Lihuang,Zha.Association of sarcopenia with the long-term risk of atrial fibrillation: A prospective cohort study.[J].Aging cell,2024,:e14198.DOI:10.1111/acel.14198.

4.Mukamengjiang,Juaiti,Yilu,Feng,Yiyang,Tang,Benhui,Liang,Lihuang,Zha,Zaixin,Yu.Integrated bioinformatics analysis and experimental animal models identify a robust biomarker and its correlation with the immune microenvironment in pulmonary arterial hypertension.[J].Heliyon,2024,10(8):e29587.DOI:10.1016/j.heliyon.2024.e2958

5.Benhui,Liang,Lihuang,Zha,Baohua,Peng,Qin,Chen,Mukamengjiang,Juaiti,Xiaofang,Zeng,Yilu,Feng,Zaixin,Yu,Yiyang,Tang.Association of Cardiovascular Health with the Incidence of Venous Thromboembolism: A Prospective Study of 275,149 Participants from the UK Biobank.[J].Thrombosis and haemostasis,2024,:.DOI:10.1055/a-2305-6631.

6.Yilu,Feng,Zaixin,Yu,Mi,Tang,Jiang,Li,Baohua,Peng,Mukamengjiang,Juaiti,Yiyang,Tang,Benhui,Liang,Mingqi,Ouyang,Qingqing,Liu,Jie,Song.Transcriptome-Wide N6-Methyladenosine Alternations in Pulmonary Arteries of Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats and Novel Therapeutic Targets.[J].Biomedicines,2024,12(2):.DOI:10.3390/biomedicines12020364.

7.Ekkehard,Grünig,Franck,Rahaghi,Jean,Elwing,Carmine Dario,Vizza,Joanna,Pepke-Zaba,Jieyan,Shen,Hua,Yao,Antoine,Hage,Stephan,Rosenkranz,Madelon,Vonk,Vijay,Balasubramanian,Yang,Yuanhua,Zaixin,Yu,James,Lordan,Linda,Cadaret,Rob,Grover,Aliou,Ousmanou,Scott,Seaman,Chunqin,Deng,Meredith,Broderick,R James,White,FREEDOM-EV Investigators.Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.[J].Advances in therapy,2024,41(2):618-637.DOI:10.1007/s12325-023-02711-x.

8.Shengwen,Liu,Yujie,Zhou,Zhujun,Shen,Hui,Chen,Chunguang,Qiu,Guosheng,Fu,Hui,Li,Zaixin,Yu,Qiutang,Zeng,Zhanquan,Li,Wei,Li,Shubin,Qiao,Dissolve SVD investigators.Comparison of Drug-Coated Balloon and Drug-Eluting Stent for the Treatment of Small Vessel Disease (from the Dissolve SVD Randomized Trial).[J].The American journal of cardiology,2024,211:29-39.DOI:10.1016/j.amjcard.2023.05.057.

9.Ying,Tian,Xinyu,Hong,Yuan,Xie,Zaixin,Guo,Qi,Yu.17β-Estradiol (E₂) Upregulates the ERα/SIRT1/PGC-1α Signaling Pathway and Protects Mitochondrial Function to Prevent Bilateral Oophorectomy (OVX)-Induced Nonalcoholic Fatty Liver Disease (NAFLD).[J].Antioxidants (Basel, Switzerland),2023,12(12):.DOI:10.3390/antiox12122100.

10.Yuling,Qian,Ruilin,Quan,Xiaoxi,Chen,Gangcheng,Zhang,Yuanhua,Yang,Yucheng,Chen,Zaixin,Yu,Qing,Gu,Changming,Xiong,Huijun,Han,Jianguo,He.Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study.[J].ERJ open research,2023,9(6):.DOI:10.1183/23120541.00495-2023.

11.Wen,Zhang,Wenchao,Lin,Xiaofang,Zeng,Mengqiu,Zhang,Qin,Chen,Yiyang,Tang,Jing,Sun,Benhui,Liang,Lihuang,Zha,Zaixin,Yu.FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.[J].Aging and disease,2023,14(5):1927-1944.DOI:10.14336/AD.2023.0218.

12.Xiaofang,Zeng,Qiong,Liu,Anandharajan,Rathinasabapathy,Lihuang,Zha,Dongliang,Liu,Yiyang,Tang,Jing,Sun,Hui,Luo,Zaixin,Yu.Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report.[J].BMC pulmonary medicine,2023,23(1):26.DOI:10.1186/s12890-023-02322-w.\

13.Yiyang,Tang,Jing,Sun,Zaixin,Yu,Benhui,Liang,Baohua,Peng,Jing,Ma,Xiaofang,Zeng,Yilu,Feng,Qin,Chen,Lihuang,Zha.Association between prothrombin time-international normalized ratio and prognosis of post-cardiac arrest patients: A retrospective cohort study.[J].Frontiers in public health,2023,11:1112623.DOI:10.3389/fpubh.2023.1112623.\

14.Yonghong,Wang,Yanfei,Liu,Aike,Fei,Zaixin,Yu.LncRNA XIST facilitates hypoxia-induced myocardial cell injury through targeting miR-191-5p/TRAF3 axis.[J].Molecular and cellular biochemistry,2022,477(6):1697-1707.DOI:10.1007/s11010-022-04385-5.

15.Ruilin,Quan,Shian,Huang,Lingpin,Pang,Jieyan,Shen,Weifeng,Wu,Fangming,Tang,Xiulong,Zhu,Weiqing,Su,Jingzhi,Sun,Zaixin,Yu,Lemin,Wang,Xianyang,Zhu,Changming,Xiong,Jianguo,He.Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics.[J].BMC cardiovascular disorders,2022,22(1):56.DOI:10.1186/s12872-022-02492-1.

16.Yiyang,Tang,Qin,Chen,Benhui,Liang,Baohua,Peng,Meijuan,Wang,Jing,Sun,Zhenghui,Liu,Lihuang,Zha,Zaixin,Yu.Corrigendum: A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure.[J].Frontiers in cardiovascular medicine,2022,9:1116632.DOI:10.3389/fcvm.2022.1116632.

17.Yiyang,Tang,Qin,Chen,Benhui,Liang,Baohua,Peng,Meijuan,Wang,Jing,Sun,Zhenghui,Liu,Lihuang,Zha,Zaixin,Yu.A retrospective cohort study on the association between early coagulation disorder and short-term all-cause mortality of critically ill patients with congestive heart failure.[J].Frontiers in cardiovascular medicine,2022,9:999391.DOI:10.3389/fcvm.2022.999391.

18.Ziwei,Ou,Zaixin,Yu,Benhui,Liang,Lin,Zhao,Jianghua,Li,Xinli,Pang,Qiyun,Liu,Cong,Xu,Shaohong,Dong,Xin,Sun,Tangzhiming,Li.Evolocumab enables rapid LDL-C reduction and inflammatory modulation during in-hospital stage of acute coronary syndrome: A pilot study on Chinese patients.[J].Frontiers in cardiovascular medicine,2022,9:939791.DOI:10.3389/fcvm.2022.939791.

19.Wenchao,Lin,Yiyang,Tang,Mengqiu,Zhang,Benhui,Liang,Meijuan,Wang,Lihuang,Zha,Zaixin,Yu.Integrated Bioinformatic Analysis Reveals TXNRD1 as a Novel Biomarker and Potential Therapeutic Target in Idiopathic Pulmonary Arterial Hypertension.[J].Frontiers in medicine,2022,9:894584.DOI:10.3389/fmed.2022.894584.

20.Xiaofang,Zeng,Xiao,Huang,Anandharajan,Rathinasabapathy,Zhe,Xu,Kai,Li,Na,Liu,Huiling,Chen,Yuandong,Jiang,Lihuang,Zha,Zaixin,Yu.Prevalence of <i>Schistosoma japonicum</i>-associated Pulmonary Hypertension in China: An Echocardiography-based Assessment.[J].Annals of the American Thoracic Society,2021,18(12):2095-2098.DOI:10.1513/AnnalsATS.202012-1573RL.

21.Bo,Zheng,Jianping,Li,Jie,Jiang,Dingcheng,Xiang,Yundai,Chen,Zaixin,Yu,Hesong,Zeng,Junbo,Ge,Xiangrong,Dai,Jiahui,Liu,Benjamin,Li,Yong,Huo.Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non-ST segment elevation myocardial infarction: A phase Ib/IIa study.[J].Pharmacotherapy,2021,41(10):828-836.DOI:10.1002/phar.2620.

22.Ruilin,Quan,Yuanhua,Yang,Zhenwen,Yang,Hongyan,Tian,Shengqing,Li,Jieyan,Shen,Yingqun,Ji,Gangcheng,Zhang,Caojin,Zhang,Guangyi,Wang,Yuhao,Liu,Zhaozhong,Cheng,Zaixin,Yu,Zhiyuan,Song,Zeqi,Zheng,Wei,Cui,Yucheng,Chen,Shuang,Liu,Xiaoxi,Chen,Yuling,Qian,Changming,Xiong,Guangliang,Shan,Jianguo,He.Risk prediction in medically treated chronic thromboembolic pulmonary hypertension.[J].BMC pulmonary medicine,2021,21(1):128.DOI:10.1186/s12890-021-01495-6.

23.Yiyang,Tang,Xiaofang,Zeng,Yilu,Feng,Qin,Chen,Zhenghui,Liu,Hui,Luo,Lihuang,Zha,Zaixin,Yu.Association of Systemic Immune-Inflammation Index With Short-Term Mortality of Congestive Heart Failure: A Retrospective Cohort Study.[J].Frontiers in cardiovascular medicine,2021,8:753133.DOI:10.3389/fcvm.2021.753133.

24.Xiaofang,Zeng,Fan,Chen,Anandharajan,Rathinasabapathy,Tangzhiming,Li,Agila,Adnan Ali Mohammed Mohammed,Zaixin,Yu.Rapid disease progress in a PVOD patient carrying a novel EIF₂AK₄ mutation: a case report.[J].BMC pulmonary medicine,2020,20(1):186.DOI:10.1186/s12890-020-01186-8.

25.Jian,Tian,Yi-da,Tang,Shubin,Qiao,Xi,Su,Yundai,Chen,Zening,Jin,Hui,Chen,Biao,Xu,Xiangqing,Kong,Wenyue,Pang,Yong,Liu,Zaixin,Yu,Xue,Li,Hui,Li,Yanyan,Zhao,Yang,Wang,Wei,Li,Changdong,Guan,Runlin,Gao,Bo,Xu,RESTORE SVD China Investigators.Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial.[J].Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2020,95 Suppl 1:587-597.DOI:10.1002/ccd.28705.

26.Geng,Wang,Genshan,Ma,Ling,Tao,Zuyi,Yuan,Huiliang,Liu,Xinqun,Hu,Qian,Tong,Zaixin,Yu,Xuchen,Zhou,Yaling,Han.Three-year follow up of biodegradable polymer cobalt-chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: Pooled analysis of CREDIT II and CREDIT III trials.[J].Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions,2020,95 Suppl 1:565-571.DOI:10.1002/ccd.28713.

27.GengWang,Genshan Ma,LingTao,ZuyiYuan,Huiliang Liu,Xinqun Hu,Qian Tong,Zaixin Yu,Xuchen Zhou,Yaling Han.Three-year follow up of biodegradable polymer cobalt-chromium sirolimus-eluting stent (EXCROSSAL) in treating de novo coronary artery disease: Pooled analysis of CREDIT II and CREDIT III trials[J].Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions,2020,95(S1):565-571.

28.Tang, Yiyang,Zha, Lihuang,Zeng, Xiaofang,Yu, Zaixin.Identification of Biomarkers Related to Systemic Sclerosis With or Without Pulmonary Hypertension Using Co-expression Analysis[J].Journal of computational biology: A journal of computational molecular cell biology,2020,27(10):1519-1531.

29.Tangzhiming,Li,Suqi,Li,Yilu,Feng,Xiaofang,Zeng,Shaohong,Dong,Jianghua,Li,Lihuang,Zha,Hui,Luo,Lin,Zhao,Bin,Liu,Ziwei,Ou,Wenchao,Lin,Mengqiu,Zhang,Sheng,Li,Qiuqiong,Jiang,Qiangqiang,Qi,Qingyao,Xu,Zaixin,Yu.Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling.[J].Oxidative medicine and cellular longevity,2020,2020:6973636.DOI:10.1155/2020/6973636.

30.Fei,Guo,Jun,Zhou,Zhenyu,Li,Zaixin,Yu,Dongsheng,Ouyang.The Association between Trimethylamine N-Oxide and Its Predecessors Choline, L-Carnitine, and Betaine with Coronary Artery Disease and Artery Stenosis.[J].Cardiology research and practice,2020,2020:5854919.DOI:10.1155/2020/5854919.

31.Yiyang,Tang,Wenchao,Lin,Lihuang,Zha,Xiaofang,Zeng,Xiaoman,Zeng,Guojun,Li,Zhenghui,Liu,Zaixin,Yu.Serum Anion Gap Is Associated with All-Cause Mortality among Critically Ill Patients with Congestive Heart Failure.[J].Disease markers,2020,2020:8833637.DOI:10.1155/2020/8833637.

32.Tangzhiming,Li,Lihuang,Zha,Hui,Luo,Suqi,Li,Lin,Zhao,Jingni,He,Xiaohui,Li,Qiangqiang,Qi,Yuwei,Liu,Zaixin,Yu.Galectin-3 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.[J].Aging and disease,2019,10(4):731-745.DOI:10.14336/AD.2018.1001.

33.Xin,Du,Yang,Zheng,Ping,Yang,Shuren,Ma,Zaixin,Yu,Xi,Su,Junbo,Ge,Maria,Leonsson-Zachrisson,Xianhong,Wang,Jing,Sun,Lu,Bai,Chang-Sheng,Ma,YINGLONG study investigators.YINGLONG: A Multicenter, Prospective, Non-Interventional Study Evaluating the Safety and Tolerability of Ticagrelor in Chinese Patients with Acute Coronary Syndrome.[J].Advances in therapy,2019,36(7):1595-1605.DOI:10.1007/s12325-019-00972-z.

34.Hui,Luo,Bin,Liu,Lin,Zhao,Jingni,He,Tangzhiming,Li,Lihuang,Zha,Xiaohui,Li,Qiangqiang,Qi,Yuwei,Liu,Zaixin,Yu.Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension.[J].Journal of the American Society of Hypertension : JASH,2017,11(10):673-683.e3.DOI:10.1016/j.jash.2017.07.009.

35.Zhaoya,Liu,Yanbo,Liu,Qian,Xu,Haiyang,Peng,Yixin,Tang,Tianlun,Yang,Zaixin,Yu,Guangjie,Cheng,Guogang,Zhang,Ruizheng,Shi.Critical role of vascular peroxidase 1 in regulating endothelial nitric oxide synthase.[J].Redox biology,2017,12:226-232.DOI:10.1016/j.redox.2017.02.022.

36.Wei,Yang,Zhaoya,Liu,Qian,Xu,Haiyang,Peng,Luyao,Chen,Xiao,Huang,Tianlun,Yang,Zaixin,Yu,Guangjie,Cheng,Guogang,Zhang,Ruizheng,Shi.Involvement of vascular peroxidase 1 in angiotensin II-induced hypertrophy of H9c2 cells.[J].Journal of the American Society of Hypertension : JASH,2017,11(8):519-529.e1.DOI:10.1016/j.jash.2016.08.002.

37.Jingni,He,Xiaohui,Li,Hui,Luo,Tangzhiming,Li,Lin,Zhao,Qiangqiang,Qi,Yuwei,Liu,Zaixin,Yu.Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.[J].Journal of the American Society of Hypertension : JASH,2017,11(5):275-289.e2.DOI:10.1016/j.jash.2017.03.008.

38.Hui Luo,Bin Liu,Lin Zhao,Jingni He,Tangzhiming Li,Lihuang Zha,Xiaohui Li,Qiangqiang Qi,Yuwei Liu,Zaixin Yu.Galectin-3 mediates pulmonary vascular remodeling in hypoxia-induced pulmonary arterial hypertension[J].Journal of the American Society of Hypertension: JASH,2017,11(10):673-683.e3.

39.Zhao, Lin,Luo, Hui,Li, Xiaohui,Li, Tangzhiming,He, Jingni,Qi, Qiangqiang,Liu, Yuwei,Yu, Zaixin.Exosomes Derived from Human Pulmonary Artery Endothelial Cells Shift the Balance between Proliferation and Apoptosis of Smooth Muscle Cells[J].Cardiology,2017,137(1):43-53.

40.Haiyang,Peng,Luyao,Chen,Xiao,Huang,Tianlun,Yang,Zaixin,Yu,Guangjie,Cheng,Guogang,Zhang,Ruizheng,Shi.Vascular peroxidase 1 up regulation by angiotensin II attenuates nitric oxide production through increasing asymmetrical dimethylarginine in HUVECs.[J].Journal of the American Society of Hypertension : JASH,2016,10(9):741-751.e3.DOI:10.1016/j.jash.2016.06.036.

41.Wen-Jun,Shen,Zaixin,Yu,Shailja,Patel,Dyron,Jue,Li-Fen,Liu,Fredric B,Kraemer.Hormone-sensitive lipase modulates adipose metabolism through PPARγ.[J].Biochimica et biophysica acta,2011,1811(1):9-16.DOI:10.1016/j.bbalip.2010.10.001.

42.Lin,Zhao,Hui,Luo,Xiaohui,Li,Tangzhiming,Li,Jingni,He,Qiangqiang,Qi,Yuwei,Liu,Zaixin,Yu.Exosomes Derived from Human Pulmonary Artery Endothelial Cells Shift the Balance between Proliferation and Apoptosis of Smooth Muscle Cells.[J].Cardiology,137(1):43-53.DOI:10.1159/000453544.

43.Benhui,Liang,Yiyang,Tang,Shien,Li,Xinyi,Zhou,Mukamengjiang,Juaiti,Lihuang,Zha,Zaixin,Yu,Meijuan,Wang,Yilu,Feng.Association between red blood cell distribution width and the all-cause mortality of patients with aortic stenosis: A retrospective study.[J].Heart & lung : the journal of critical care,67:191-200.DOI:10.1016/j.hrtlng.2024.04.020.

44.刘博清,余再新.连续冠状动脉CT血管造影评估动脉粥样硬化斑块逆转治疗的研究进展[J].中国介入心脏病学杂志,2023,31(10):775-780.DOI:10.3969/j.issn.1004-8812.2023.10.009.

45.曾小曼,余再新,陈泽江,张腊喜,曾小慧,黄海燕,邱勋雾,符大鹏,许辉,林克利,郑应卓.心力衰竭合并肺部感染病原学特征及相关因素分析[J].中国病原生物学杂志,2023,18(4):469-472,477.DOI:10.13350/j.cjpb.230420.

46.唐益阳,余再新.调节性坏死在心肌缺血再灌注损伤中作用的研究进展[J].中华心血管病杂志,2021,49(1):85-89.DOI:10.3760/cma.j.cn112148-20200311-00189.

47.李发美,余再新.神经酰胺的功能及其在肺动脉高压中的作用[J].基础医学与临床,2021,41(2):267-271.

48.罗辉,余再新,钟旭,傅广,马丽霞,李靖,廖春锋,何仲春.微导管同侧双重造影术在CTO病变前向介入治疗中的应用研究[J].医学临床研究,2020,37(7):1057-1060.DOI:10.3969/j.issn.1671-7171.2020.07.031.

49.陆胜,余再新,黄友良,谭碧峰.不同剂量替罗非班联合替格瑞洛对NSTEMI患者短期心血管事件及血小板聚集率的影响[J].心脏杂志,2017,29(4):427-430.DOI:10.13191/j.chj.2017.0108.

50.赵林,袁安慧,王晓建,荆志成,余再新.肺动脉高压遗传修饰因素的研究进展[J].中华心血管病杂志,2016,44(9):817-820.DOI:10.3760/cma.j.issn.0253-3758.2016.09.020.

51.王晓彤,黄石安,苏伟青,沈节艳,伍伟峰,唐方明,莫观海,孙景芝,余再新,朱鲜阳,王乐民,王国干,罗鹏,李雯,孙灵跃,曾晓春,朱秀龙,吴德光,刘琼,陈火元,陈建英,黄丽,熊长明,倪新海,顾晴,罗勤,赵智慧,柳志红,何建国.国家左心衰竭所致肺动脉高压患者登记注册研究基线数据分析[J].中国循环杂志,2016,31(z1):8-8.DOI:10.3969/j.issn.1000-3614.2016.z1.018.

52.彭道地,刘琼,谢伟,余再新,邹鹏.大剂量瑞舒伐他汀钙治疗老年冠心病合并高脂血症的疗效观察[J].现代生物医学进展,2015,15(31):6068-6070.DOI:10.13241/j.cnki.pmb.2015.31.019.

53.刘琼,杨天伦,余再新.2009至2013年湘雅医院肺高血压患者的分类和诊治特点[J].中华心血管病杂志,2014,42(12):1006-1009.DOI:10.3760/cma.j.issn.0253–3758.2014.12.007.

54.宋洁,余再新.内皮素受体拮抗剂在肺动脉高压治疗中的应用[J].临床药物治疗杂志,2013,(6):5-10.DOI:10.3969/j.issn.1672-3384.2013.06.002.

55.余再新,吴春风,杨天伦,孙明.补心气口服液对慢性稳定型心绞痛患者生活质量影响及疗效观察[J].临床心血管病杂志,2011,27(2):116-118.DOI:10.3969/j.issn.1001-1439.2011.02.012.

56.代立志,蒋鑫,王勇,余再新,姚桦,王广义,吴炳祥,荆志成.波生坦治疗特发性肺动脉高压患者的疗效及安全性[J].中华心血管病杂志,2011,39(2):124-127.DOI:10.3760/cma.j.issn.0253-3758.2011.02.008.

57.张茜,余再新,欧细平,杨天伦.左、右心功能不全患者氨基末端B型利钠肽前体水平的比较[J].中华老年多器官疾病杂志,2010,09(3):209-213.DOI:10.3969/j.issn.1671-5403.2010.03.005.

58.杨瑛,余再新.冠状动脉支架术四联抗凝促发大出血2例[J].临床心血管病杂志,2008,24(2):159-160.DOI:10.3969/j.issn.1001-1439.2008.02.029.

59.李传昶,蒲晓群,杨天伦,郑昭芬,欧阳淑其,余再新,陈凡,莫龙,蒋冬贵,邓金华,孟霜媛.急性心肌梗死患者的直接经皮腔内冠状动脉成形术与溶栓治疗疗效比较[J].中国动脉硬化杂志,2003,11(4):359-361.DOI:10.3969/j.issn.1007-3949.2003.04.023.

Beberapa publikasi:

主编或参编著作12部参与编写的指南：《2007年中国肺动脉高压筛查诊断与治疗专家共识》、《2009年急性肺栓塞中国专家共识》、《2010年中国肺高血压诊治指南》、《2012年中国右心衰竭诊断和治疗专家共识》、《2014年中国肺高血压诊治指南》、《2016年中国经皮冠状动脉介入治疗指南》、《2019年急性ST段抬高型心肌梗死溶栓治疗的合理用药指南》、《冠状动脉生物可吸收支架临床应用中国专家共识》《关于新型冠状病毒肺炎与RAS抑制剂治疗心血管疾病的科学声明》、《新型冠状病毒感控背景下心血管病急危重症ECMO使用的中国专家共识》、《超高危动脉粥样硬化性心血管疾病患者血脂管理中国专家共识》、《常用口服抗血小板药物不耐受及低反应性人群诊疗专家共识》、《多参数监护仪临床报警管理实践指南（2020 版）》